Cargando…
A Commentary on “PTX3 is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer”
Autor principal: | Di Virgilio, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446995/ https://www.ncbi.nlm.nih.gov/pubmed/26075183 http://dx.doi.org/10.3389/fonc.2015.00118 |
Ejemplares similares
-
PTX3 acts as an extrinsic oncosuppressor
por: Bonavita, Eduardo, et al.
Publicado: (2015) -
Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer
por: Rubino, Marcello, et al.
Publicado: (2017) -
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma
por: Mazzoni, M., et al.
Publicado: (2022) -
Updates on HIPK2: a resourceful oncosuppressor for clearing cancer
por: D’Orazi, Gabriella, et al.
Publicado: (2012) -
Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
por: Kampo, Sylvanus, et al.
Publicado: (2019)